XYLO TECHNOLOGIES LTD (XYLO) Fundamental Analysis & Valuation

NASDAQ:XYLO • US58471G5080

Current stock price

5.07 USD
0 (0%)
At close:
5.29 USD
+0.22 (+4.34%)
After Hours:

This XYLO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. XYLO Profitability Analysis

1.1 Basic Checks

  • XYLO had negative earnings in the past year.
  • In the past year XYLO has reported a negative cash flow from operations.
XYLO Yearly Net Income VS EBIT VS OCF VS FCFXYLO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

  • XYLO has a Return On Assets of -16.05%. This is comparable to the rest of the industry: XYLO outperforms 54.45% of its industry peers.
  • Looking at the Return On Equity, with a value of -33.51%, XYLO is in line with its industry, outperforming 54.97% of the companies in the same industry.
Industry RankSector Rank
ROA -16.05%
ROE -33.51%
ROIC N/A
ROA(3y)-17.06%
ROA(5y)N/A
ROE(3y)-42.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XYLO Yearly ROA, ROE, ROICXYLO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • With a Gross Margin value of 22.38%, XYLO is not doing good in the industry: 78.01% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of XYLO has declined.
  • XYLO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.16%
GM growth 5YN/A
XYLO Yearly Profit, Operating, Gross MarginsXYLO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. XYLO Health Analysis

2.1 Basic Checks

  • XYLO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for XYLO has been increased compared to 1 year ago.
  • The debt/assets ratio for XYLO is higher compared to a year ago.
XYLO Yearly Shares OutstandingXYLO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 500K 1M 1.5M
XYLO Yearly Total Debt VS Total AssetsXYLO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • XYLO has an Altman-Z score of -3.16. This is a bad value and indicates that XYLO is not financially healthy and even has some risk of bankruptcy.
  • XYLO has a Altman-Z score of -3.16. This is in the lower half of the industry: XYLO underperforms 64.40% of its industry peers.
  • A Debt/Equity ratio of 0.07 indicates that XYLO is not too dependend on debt financing.
  • XYLO's Debt to Equity ratio of 0.07 is fine compared to the rest of the industry. XYLO outperforms 63.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -3.16
ROIC/WACCN/A
WACC8.8%
XYLO Yearly LT Debt VS Equity VS FCFXYLO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

  • A Current Ratio of 1.14 indicates that XYLO should not have too much problems paying its short term obligations.
  • XYLO has a worse Current ratio (1.14) than 84.82% of its industry peers.
  • XYLO has a Quick Ratio of 1.14. This is a normal value and indicates that XYLO is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.14, XYLO is doing worse than 70.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.14
XYLO Yearly Current Assets VS Current LiabilitesXYLO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. XYLO Growth Analysis

3.1 Past

  • XYLO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.37%, which is quite impressive.
  • XYLO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -67.45%.
  • Measured over the past years, XYLO shows a very strong growth in Revenue. The Revenue has been growing by 43.44% on average per year.
EPS 1Y (TTM)66.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%123.26%
Revenue 1Y (TTM)-67.45%
Revenue growth 3Y43.44%
Revenue growth 5YN/A
Sales Q2Q%-72.47%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y1216.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.71%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XYLO Yearly Revenue VS EstimatesXYLO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
XYLO Yearly EPS VS EstimatesXYLO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 5 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

4

4. XYLO Valuation Analysis

4.1 Price/Earnings Ratio

  • XYLO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 0.79, which indicates a rather cheap valuation of XYLO.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of XYLO indicates a rather cheap valuation: XYLO is cheaper than 100.00% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of XYLO to the average of the S&P500 Index (38.00), we can say XYLO is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.79
XYLO Price Earnings VS Forward Price EarningsXYLO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XYLO Per share dataXYLO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XYLO Dividend Analysis

5.1 Amount

  • XYLO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

XYLO Fundamentals: All Metrics, Ratios and Statistics

XYLO TECHNOLOGIES LTD

NASDAQ:XYLO (8/21/2025, 8:00:02 PM)

After market: 5.29 +0.22 (+4.34%)

5.07

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.07%
Inst Owner Change-99.68%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.61M
Revenue(TTM)29.86M
Net Income(TTM)-6.03M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.79
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 0.53
P/tB 2.99
EV/EBITDA N/A
EPS(TTM)-3.46
EYN/A
EPS(NY)6.45
Fwd EY127.15%
FCF(TTM)-0.97
FCFYN/A
OCF(TTM)-0.96
OCFYN/A
SpS15.76
BVpS9.49
TBVpS1.7
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -16.05%
ROE -33.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.38%
FCFM N/A
ROA(3y)-17.06%
ROA(5y)N/A
ROE(3y)-42.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.16%
GM growth 5YN/A
F-Score4
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.32%
Cap/Sales 0.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.14
Altman-Z -3.16
F-Score4
WACC8.8%
ROIC/WACCN/A
Cap/Depr(3y)15.51%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%123.26%
EPS Next Y1216.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-67.45%
Revenue growth 3Y43.44%
Revenue growth 5YN/A
Sales Q2Q%-72.47%
Revenue Next Year5.71%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.8%
OCF growth 3YN/A
OCF growth 5YN/A

XYLO TECHNOLOGIES LTD / XYLO Fundamental Analysis FAQ

What is the fundamental rating for XYLO stock?

ChartMill assigns a fundamental rating of 2 / 10 to XYLO.


What is the valuation status of XYLO TECHNOLOGIES LTD (XYLO) stock?

ChartMill assigns a valuation rating of 4 / 10 to XYLO TECHNOLOGIES LTD (XYLO). This can be considered as Fairly Valued.


What is the profitability of XYLO stock?

XYLO TECHNOLOGIES LTD (XYLO) has a profitability rating of 1 / 10.


Can you provide the financial health for XYLO stock?

The financial health rating of XYLO TECHNOLOGIES LTD (XYLO) is 2 / 10.